Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes
Open Access
- 14 May 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 12
Abstract
Combined activation of GLP-1 and CCK1 receptors has potential to synergistically augment the appetite-suppressive and glucose homeostatic actions of the individual parent peptides. In the current study, pancreatic beta-cell benefits of combined GLP-1 and CCK1 receptor upregulation were established, before characterising bioactivity and antidiabetic efficacy of an acylated dual-acting GLP-1/CCK hybrid peptide, namely [Lys12Pal]Ex-4/CCK. Both exendin-4 and CCK exhibited (p12Pal]Ex-4/CCK exhibited prominent insulinotropic actions in vitro, coupled with beneficial (p12Pal]Ex-4/CCK for 28 days in diabetic high fat fed (HFF) mice with streptozotocin (STZ)-induced compromised beta-cells, there were clear reductions (p12Pal]Ex-4/CCK for the treatment of obesity-related diabetes.Keywords
Funding Information
- European Foundation for the Study of Diabetes
- Department for the Economy
This publication has 51 references indexed in Scilit:
- (pGlu-Gln)-CCK-8[mPEG]: A novel, long-acting, mini-PEGylated cholecystokinin (CCK) agonist that improves metabolic status in dietary-induced diabetesBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Comparison of independent and combined metabolic effects of chronic treatment with ( pGlu ‐Gln)‐ CCK ‐8 and long‐acting GLP ‐1 and GIP mimetics in high fat‐fed miceDiabetes, Obesity and Metabolism, 2013
- Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesityClinical Science, 2011
- Control of Pancreatic β Cell Regeneration by Glucose MetabolismCell Metabolism, 2011
- Cholecystokinin Is Up-Regulated in Obese Mouse Islets and Expands β-Cell Mass by Increasing β-Cell SurvivalEndocrinology, 2010
- Evaluation of interactions between CCK and GLP-1 in their effects on appetite, energy intake, and antropyloroduodenal motility in healthy menAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2005
- Satiety effects of a physiological dose of cholecystokinin in humans.Gut, 1995
- Interaction of Glucagon-like Peptide- 1 (7-36)amide and Cholecystokinin-8 in the Endocrine and Exocrine Rat PancreasPancreas, 1990
- Rapid development of tolerance to the behavioural actions of cholecystokininNature, 1983
- Cholecystokinin decreases food intake in rats.Journal of Comparative and Physiological Psychology, 1973